Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00919100 · ClinicalTrials.gov registry record · NA

Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief

A NA study of Pain, sponsored by Georgia State University.

Completed
Registry status
NA
Development phase
81
Enrollment target
1
Study location

NCT00919100 is a NA study of Pain that has completed, run by Georgia State University. The registered enrollment target is 81 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00919100, a NA study of Pain, has completed, sponsored by Georgia State University.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target
1
Study location

Study Summary

A vibrating cold pack placed proximal to the site of venipuncture will decrease the pain of cannulation when compared to vapocoolant spray.

Conditions Studied

Interventions

  • DEVICE Buzzy
  • OTHER vapocoolant

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta, Scottish Rite - Atlanta

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2008-04
Est. Completion 2008-08
Phase NA

Sponsor

Georgia State University

45 total trials

What the Registry Record Tells You About NCT00919100

The ClinicalTrials.gov registry entry for NCT00919100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (73% lower). The listed sponsor is Georgia State University, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Buzzy is the first listed.

NCT00919100 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00919100 about?

NCT00919100 is a clinical study titled "Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief". A vibrating cold pack placed proximal to the site of venipuncture will decrease the pain of cannulation when compared to vapocoolant spray.

What is the current status of trial NCT00919100?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2008-04. Estimated completion is 2008-08.

What conditions does trial NCT00919100 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00919100?

The interventions under investigation include: Buzzy (DEVICE), vapocoolant (OTHER).

Who is sponsoring clinical trial NCT00919100?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00919100 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.